March 2024 Norton Children’s Medical Group New Providers
Pamela C Biddle, M.D. Pediatrics Jessica N.B. Easterling, M.D. Pediatrics Kelly E Kries, MD Pediatrics Casey L Miles, MD Pediatrics Danielle R. Lunsford, APRN Developmental-Behavioral Pediatrics Mary C. Oechslin, APRN Pediatrics Chelsea R. Sabelhaus, […]
View moreMarch 2024 Norton Medical Group new providers
Paul A. Kniery, M.D. Internal Medicine Stephen Love, M.D. Behavioral Medicine Sarah A. Mayfield, M.D. Internal Medicine Emmanuel A. Nidhiry, M.D. Medical Oncology and Hematology Anupama Raghuram, M.D. Infectious Diseases Elizabeth Fahey, PA-C Hand Surgery […]
View moreUpdated information on lecanemab infusions for mild cognitive impairment and Alzheimer’s
In 2023, the Food and Drug Administration (FDA) approved lecanemab (brand name Leqembi) for the treatment of Alzheimer’s disease. Lecanemab is the first widely used medication in a new class of anti-amyloid agents for the […]
View moreNorton Healthcare, Norton Children’s launch $200 million fundraising campaign
Not-for-profit Norton Healthcare and Norton Children’s ask for the community’s help to improve health and quality of life for every person in Kentucky and Southern Indiana. The organization, along with local and community leaders, announced […]
View moreNorton Louisville Arm & Hand becomes Norton Arm & Hand Institute
Norton Arm & Hand Institute is the new name for Norton Louisville Arm & Hand, as of March 1, 2024. The goal of Norton Arm & Hand Institute is to be a destination program by […]
View moreOpen-access, peer-reviewed medical journal accepting submissions
Norton Healthcare has launched a new, open-access medical journal to promote the sharing of innovation and ideas from the laboratory, the bedside and everyday practice. Norton Healthcare Medical Journal welcomes original articles related to medicine, […]
View moreAntimicrobial stewardship
The Norton Healthcare Antimicrobial Stewardship Program was recognized this year as the first and only antimicrobial stewardship center of excellence in the United States by the British Society of Antimicrobial Chemotherapy. The international collaboration is […]
View moreNorton Cancer Institute enrolling patients for gotistobart (ONC-392) Phase 3 trial
Norton Cancer Institute is enrolling metastatic lung cancer patients in a Phase 3 clinical trial to test a promising new anti-CLTA-4 antibody, gotistobart (ONC-392). The study will test whether gotistobart is more effective than the [...]
View moreChristopher P. Rhyne, M.D., headache medicine specialist, has joined Norton Neuroscience Institute
Christopher P. Rhyne, M.D., is a headache medicine specialist at Norton Neuroscience Institute. He earned his medical degree from Windsor University School of Medicine, St. Kitts, West Indies. He completed his residency in family medicine […]
View moreFebruary 2024 Norton Medical Group new providers
Scott M. McClain, M.D. Emergency Medicine Stephen R. Roszell, M.D. Urgent Care Jerome J. Tuitt, M.D. Hospital Medicine Shengnan Zheng, M.D. Hospital Medicine Timothy J. Ziolkowski, M.D. Emergency Medicine Katharine Adelstein, APRN Psycho-oncology Lunden A. […]
View moreFebruary 2024 Norton Children’s Medical Group New Providers
Patrick K. Hynes, M.D. Pediatrics Anna M. Boone, APRN Pediatric Neurology Elizabeth S. Deitz, APRN Neonatology Brianna S. Redman, APRN Pediatrics Catherine Thornberry, LCSW Maternal-Fetal Medicine
View moreLouisville Business First has recognized Norton Healthcare and Norton Children’s research team members with its 2024 Health Care Heroes Innovator Award
Louisville Business First has recognized researchers at Norton Healthcare with its 2024 Health Care Heroes Innovator Award. The award honors those who break ground in the health care field by developing or implementing new technology, [...]
View more